CAMP4 Therapeutics Corp. (CAMP)
4.15
-0.02
(-0.48%)
USD |
NASDAQ |
Sep 22, 16:00
4.15
0.00 (0.00%)
After-Hours: 20:00
CAMP4 Therapeutics Total Assets (Quarterly) : 93.43M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 93.43M |
| March 31, 2026 | 105.46M |
| December 31, 2025 | 117.81M |
| September 30, 2025 | 86.40M |
| June 30, 2025 | 51.28M |
| March 31, 2025 | 62.77M |
| Date | Value |
|---|---|
| December 31, 2024 | 78.31M |
| September 30, 2024 | 21.36M |
| June 30, 2024 | 29.94M |
| March 31, 2024 | |
| December 31, 2023 | 54.95M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| MannKind Corp. | 732.30M |
| Ocugen, Inc. | 124.21M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 94.12M |
| Shareholders Equity (Quarterly) | -0.693M |
| Debt to Equity Ratio | -3.423 |
| Current Ratio | 4.703 |
| Net Debt Paydown Yield | 0.49% |